Structural basis of organic cation transporter-3 inhibition
Open Access
- 7 November 2022
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-13
Abstract
Organic cation transporters (OCTs) facilitate the translocation of catecholamines, drugs and xenobiotics across the plasma membrane in various tissues throughout the human body. OCT3 plays a key role in low-affinity, high-capacity uptake of monoamines in most tissues including heart, brain and liver. Its deregulation plays a role in diseases. Despite its importance, the structural basis of OCT3 function and its inhibition has remained enigmatic. Here we describe the cryo-EM structure of human OCT3 at 3.2 Å resolution. Structures of OCT3 bound to two inhibitors, corticosterone and decynium-22, define the ligand binding pocket and reveal common features of major facilitator transporter inhibitors. In addition, we relate the functional characteristics of an extensive collection of previously uncharacterized human genetic variants to structural features, thereby providing a basis for understanding the impact of OCT3 polymorphisms.Keywords
All Related Versions
This publication has 47 references indexed in Scilit:
- Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significanceBMC Cancer, 2012
- The cysteines of the extracellular loop are crucial for trafficking of human organic cation transporter 2 to the plasma membrane and are involved in oligomerizationThe FASEB Journal, 2011
- The Large Extracellular Loop of Organic Cation Transporter 1 Influences Substrate Affinity and Is Pivotal for OligomerizationJournal of Biological Chemistry, 2011
- SLC6 Neurotransmitter Transporters: Structure, Function, and RegulationPharmacological Reviews, 2011
- Natural and synthetic corticosteroids inhibit uptake2-mediated transport in CNS neuronsPhysiology & Behavior, 2011
- Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metforminPharmacogenetics and Genomics, 2010
- Structure of a fucose transporter in an outward-open conformationNature, 2010
- Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver†Hepatology, 2009
- Significance of Organic Cation Transporter 3 (SLC22A3) Expression for the Cytotoxic Effect of Oxaliplatin in Colorectal CancerDrug Metabolism and Disposition, 2008
- Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3British Journal of Pharmacology, 2002